Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) traded up 14.3% during mid-day trading on Thursday . The stock traded as high as $0.32 and last traded at $0.32. Approximately 86,573 shares were traded during mid-day trading, an increase of 1,568% from the average session volume of 5,191 shares. The stock had previously closed at $0.28.
Guided Therapeutics Price Performance
The firm has a market cap of $28.96 million, a PE ratio of -7.50 and a beta of 0.72. The business’s 50 day moving average price is $0.23 and its 200 day moving average price is $0.29.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.01) earnings per share for the quarter.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.
The company secured 510(k) clearance from the U.S.
Further Reading
- Five stocks we like better than Guided Therapeutics
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
